Five_CD year_NN summary_NN 12_CD months_NNS to_TO 12_CD months_NNS to_TO 12_CD months_NNS to_TO 12_CD months_NNS to_TO 12_CD months_NNS to_TO 31_CD Dec_NNP 1999_CD 31_CD Dec_NNP 2000_CD 31_CD Dec_NNP 2001_CD 31_CD Dec_NNP 2002_CD 31_CD Dec_NNP 2003_CD restated_VBN restated_VBN restated_VBN m_FW m_FW m_FW m_FW m_FW Key_NNP data_NNS Sales_NNS 1,375_CD 1,378_CD 1,603_CD 1,618_CD 1,652_CD 1,271_CD 1,378_CD 1,603_CD 1,618_CD 1,652_CD continuing_VBG operations_NNS discontinued_VBN operations_NNS 104_CD -_: -_: -_: -_: Amersham_NNP Health_NNP 178 195 241 256_CD 228_CD Amersham_NNP Biosciences_NNP 82_CD 63_CD 72_CD 75_CD 97_CD Corporate_JJ 10_CD 17_CD 21_CD 21_CD 26_CD Operating_NN profit_NN of_IN continuing_VBG operations_NNS before_IN exceptional_JJ items_NNS and_CC goodwill_NN 299_CD amortisation_NN 250 241 292 310_CD Discontinued_VBN operations_NNS 10_CD -_: -_: -_: -_: Total_JJ operating_NN profit_NN before_IN exceptional_JJ items_NNS and_CC goodwill_NN amortisation_NN 260 241 292 310_CD 299_CD Interest_NN 27_CD 10_CD 9_CD 7_CD 5_CD Amounts_NNS written_VBN off_RP investments_NNS -_: -_: 4_CD 2_LS -_: Profit_NN before_IN tax_NN and_CC before_IN exceptional_JJ items_NNS and_CC goodwill_NN amortisation_NN 233 231 279 301_CD 294_CD Exceptional_JJ items_NNS 55_CD 27_CD 47_CD -_: 58_CD Goodwill_NNP amortisation_NN 9_CD 11_CD 12_CD 37_CD 44_CD Profit_NN before_IN taxation_NN after_IN exceptional_JJ items_NNS and_CC goodwill_NN amortisation_NN 169 193 314 264_CD 192_CD Profit_NN attributable_JJ to_TO shareholders_NNS 88 107 211 179_CD 116_CD Employment_NNP of_IN shareholders_NNS funds_NNS Fixed_JJ assets_NNS 677 777 788_CD 1,491_CD 1,498_CD Net_JJ current_JJ assets_NNS 360 266 270 147_CD 92_CD Non-current_JJ liabilities_NNS incl_NN ._.
Figures_NNS for_IN periods_NNS ending_VBG 31_CD December_NNP 1999_CD ,_, 2000_CD and_CC 2001_CD have_VBP been_VBN restated_VBN following_VBG the_DT introduction_NN of_IN FRS_NNP 19_CD in_IN the_DT year_NN ended_VBD 31_CD December_NNP 2002_CD ._.
During_IN the_DT period_NN ending_VBG 31_CD December_NNP 2003_CD ,_, the_DT results_NNS of_IN Amersham_NNP Biosciences_NNPS have_VBP been_VBN further_JJ segmented_JJ into_IN Protein_NNP Separations_NNP and_CC Discovery_NNP Systems_NNPS ._.
The_DT current_JJ and_CC comparative_JJ information_NN can_MD be_VB found_VBN in_IN note_NN 1_CD to_TO the_DT financial_JJ statements_NNS ._.
